[performance forecast] Zhifei biology: net profit in 2018 increased by 223% to 252%
-
Last Update: 2019-01-04
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Zhifei Biology (300122) released the performance forecast on the evening of January 3 It is estimated that the net profit in 2018 will be 1.396 billion yuan to 1.522 billion yuan, a year-on-year increase of 223% to 252% During the reporting period, the company's sales of independent products represented by AC Hib triple vaccine continued to maintain a good growth trend, and the agency products represented by HPV vaccine successively won the bidding and sold in domestic provincial units, with the sales volume steadily rising The full text of the announcement is as follows:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
